pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,126 catalysts · 5,811 phase readout · 2,309 8k filing · 420 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 40 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 16 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,811
  • 8k filing2,309
  • earnings420
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06793085: Pro- and Anti-inflammatory Cytokines in PCOS

Sponsor: Jagiellonian University. Phase: . Conditions: Reproductive Age, PCOS (Polycystic Ovary Syndrome)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07476885: A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological Diseases

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: . Conditions: Drug-Induced Liver Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06661343: Pre-exposure Prophylaxis (PrEP) Adherence for Black MSM

Sponsor: Yale University. Phase: NA. Conditions: HIV Prevention

full page →ctgov ↗
›RECRUITINGphase readoutNCT05708443: Effect of Combined Endurance Training on ADL and Walking in COPD Patients

Sponsor: Istituti Clinici Scientifici Maugeri SpA. Phase: NA. Conditions: COPD

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07618143: The Effects of Somatic-Based Chair Exercises in the Elderly

Sponsor: Istanbul Gedik University. Phase: NA. Conditions: Elderly (People Aged 65 or More)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07471815: Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy

Sponsor: Harbin Medical University. Phase: PHASE2. Conditions: Breast Cancer Triple Negative Breast Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07544615: Assessment of IOP After Corneal Refractive Surgery Based on AI

Sponsor: Tianjin Eye Hospital. Phase: . Conditions: Myopia, Myopia; Astigmatism, Refractive Surgery, Intraocular Pressure Changes

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03240315: Personalized Prediction Strategy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Sponsor: Guangzhou Institute of Respiratory Disease. Phase: . Conditions: Pulmonary Disease, Chronic Obstructive

full page →ctgov ↗
›RECRUITINGphase readoutNCT07326215: A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+

Sponsor: Vantive Health LLC. Phase: NA. Conditions: Acute Respiratory Distress Syndrome, Acute Kidney Injury

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02014415: Alpha-1 Antitrypsin Deficiency Adult Liver Study

Sponsor: St. Louis University. Phase: . Conditions: Alpha-1 Antitrypsin Deficiency

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03157635: Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria

Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Paroxysmal Hemoglobinuria, Nocturnal

full page →ctgov ↗
›COMPLETEDphase readoutNCT05062785: Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants

Sponsor: Robert Silbergleit. Phase: PHASE1. Conditions: Out-Of-Hospital Cardiac Arrest, Healthy

full page →ctgov ↗
›COMPLETEDphase readoutNCT03677908: Plasticity of Neonatal Neuronal Networks Temporal Theta Activity, the First Endogenous

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Premature Birth

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07427225: Dual-Task vs. Multicomponent Exercise in Institutionalized Seniors

Sponsor: Instituto Politécnico de Leiria. Phase: NA. Conditions: Fear of Falling

full page →ctgov ↗
›RECRUITINGphase readoutNCT05111925: Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement

Sponsor: Womack Army Medical Center. Phase: . Conditions: Musculoskeletal Injuries

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07528625: Behavioral Interventions as Primary Prevention for Non-Communicable Diseases Among Young People

Sponsor: Deraya University. Phase: NA. Conditions: Non Communicable Diseases, Non Communicable Chronic Diseases

full page →ctgov ↗
›TERMINATEDphase readoutNCT03329976: Validation of a Prognostic Score for Good Visual Recovery at One Year Following Combined Surgery for Cataract and Idiopathic Epiretinal Membrane

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Surgery for Cataract, Surgery for and Idiopathic Epiretinal Membrane

full page →ctgov ↗
›RECRUITINGphase readoutNCT06842576: Health Care Transition Readiness Short-Form Video Intervention

Sponsor: Children's Hospital Los Angeles. Phase: NA. Conditions: Health Care Transition Readiness, Health Literacy, Self Efficacy, Emotional Wellbeing, Appointment Attendance

full page →ctgov ↗
›RECRUITINGphase readoutNCT06108076: Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

Sponsor: The University of Texas Health Science Center at San Antonio. Phase: EARLY_PHASE1. Conditions: Type 2 Diabetes, Heart Failure, Reduced Ejection Fraction

full page →ctgov ↗
›COMPLETEDphase readoutNCT04171817: Animal-Assisted Visitation Program Chlorhexidine Trial

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: PHASE4. Conditions: Methicillin-resistant Staphylococcus Aureus, Clostridium Difficile, Pseudomonas Aeruginosa

full page →ctgov ↗
›RECRUITINGphase readoutNCT07124117: A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors

Sponsor: OBI Pharma, Inc. Phase: PHASE1. Conditions: Advanced Solid Tumor

full page →ctgov ↗
›COMPLETEDphase readoutNCT01859117: Study of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers

Sponsor: Celularity Incorporated. Phase: PHASE1. Conditions: Peripheral Arterial Disease, Diabetic Foot Ulcer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05555940: Effect of Individualized Precise TMS on Emotional Blunting in Depression and Its Brain Imaging Mechanism

Sponsor: Xijing Hospital. Phase: NA. Conditions: Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT05355389: Cognitive-motor Telerehabilitation in MS

Sponsor: Universitair Ziekenhuis Brussel. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07319468: Effect of Exercises on Hemodialysis

Sponsor: Cairo University. Phase: NA. Conditions: Hemodialytic Patients

full page →ctgov ↗
›RECRUITINGphase readoutNCT03721068: Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: PHASE1. Conditions: Neuroblastoma, Osteosarcoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT03898206: Effects of Breaking up Prolonged Sitting on Postprandial Cardiometabolic Disease Risk Markers in South Asian Adults

Sponsor: University of Bedfordshire. Phase: NA. Conditions: Cardiovascular Risk Factor, Cardiovascular Diseases, Diabetes, Physical Activity, Sedentary Lifestyle

full page →ctgov ↗
›COMPLETEDphase readoutNCT07177404: Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes

Sponsor: University of Nottingham. Phase: . Conditions: Diabete Mellitus, Type 1 Diabetes Mellitus

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07662304: Effect of Continuous Supraglottic Oxygen Insufflation Via Video Laryngoscope Blade on Apneic Oxygenation During Tracheal Intubation Under General Anesthesia

Sponsor: Affiliated Hospital of Jiaxing University. Phase: NA. Conditions: Apneic Oxygenation

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06106204: Reducing Overuse of Antibiotics at Discharge Home

Sponsor: University of Utah. Phase: NA. Conditions: Pneumonia, Urinary Tract Infection, Antibiotic Stewardship, Care Transition

full page →ctgov ↗
›COMPLETEDphase readoutNCT05794204: RMP-A03 Ocular Suspension in Patients With Pterygium

Sponsor: Suzhou Raymon Pharmaceuticals Company, Ltd.. Phase: PHASE2. Conditions: Pterygium

full page →ctgov ↗
›RECRUITINGphase readoutNCT06572384: A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Sponsor: GlaxoSmithKline. Phase: PHASE3. Conditions: Lung Diseases, Interstitial

full page →ctgov ↗
›RECRUITINGphase readoutNCT06931652: Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab

Sponsor: The Lymphoma Academic Research Organisation. Phase: PHASE2. Conditions: Primary CNS Lymphoma (PCNSL)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06849752: Early Assessment and Initiation of GuideLine-Directed Evidence-Based Management-HF

Sponsor: The Cleveland Clinic. Phase: . Conditions: Heart Failure, Socioeconomic Adversity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07398352: Comparison Of The Effects Of Regional Anesthesia On Brain And Carotid Artery Oxygenation In Shoulder Surgery

Sponsor: Sanliurfa Mehmet Akif Inan Education and Research Hospital. Phase: NA. Conditions: Interscalene Block, Superficial Cervical Block, Cerebral Perfusion, Shoulder Surgeries

full page →ctgov ↗
›COMPLETEDphase readoutNCT05880849: Choline Effects - Pre-symptomatic AD

Sponsor: Paul E Schulz. Phase: PHASE1. Conditions: Alzheimer Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06694584: Study: Tea(m)Time - Strengthening the Team Resilience of Hospital Staff Through the Tea(m)Time Intervention

Sponsor: Catholic University of Applied Sciences Mainz. Phase: NA. Conditions: Resilience, Psychological, Personnel, Hospital

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07594938: Studying Fatigue and Movement After Stroke

Sponsor: Vrije Universiteit Brussel. Phase: . Conditions: Stroke, Cerebro-vascular Accident, Ischemia Stroke, Hemorrhage Stroke

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05833438: Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy

Sponsor: University of Leipzig. Phase: PHASE2. Conditions: Acute Myeloid Leukemia (AML)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03447938: The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial

Sponsor: Ottawa Heart Institute Research Corporation. Phase: NA. Conditions: Coronary Artery Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05934838: A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

Sponsor: Weill Medical College of Cornell University. Phase: PHASE1. Conditions: Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06788938: Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms

Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE2. Conditions: DLL3-expressing Tumors, Advanced Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT06842238: Descriptive Study of the Initial Management of Young Children With Moderate Acute BRONCHiotitis With Home Hospitalisation

Sponsor: Elsan. Phase: . Conditions: Bronchiolitis, Bronchiolitis Acute

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01274338: Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Melanoma of Unknown Primary, Recurrent Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7

full page →ctgov ↗
›TERMINATEDphase readoutNCT06983158: A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy

Sponsor: Capsida Biotherapeutics, Inc.. Phase: PHASE1. Conditions: Developmental and Epileptic Encephalopathy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07308158: Covid Flu A/B and RSV 4 in 1 Diagnostic Test

Sponsor: iHealth Labs inc. Phase: . Conditions: Influenza A, Influenza B, COVID - 19, RSV

full page →ctgov ↗
›RECRUITINGphase readoutNCT06697158: Investigation of the Effects of Complex Decongestive Physiotherapy on Sleep Quality and Quality of Life in Women With Breast Cancer Related Lymphedema

Sponsor: Abant Izzet Baysal University. Phase: NA. Conditions: Breast Cancer Related Lymphedema

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07591948: The Effect of Low-Level Laser Therapy on Accelerating Tooth Movement and Reducing Pain During Orthodontic Treatment

Sponsor: Sana'a University. Phase: NA. Conditions: Acceleration of Tooth Movement

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05003648: Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy

Sponsor: Massachusetts General Hospital. Phase: PHASE4. Conditions: Adrenoleukodystrophy, Restless Legs Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07664748: Artificial Voice Analysis and Telemonitoring for Heart Failure. A Feasibility Study

Sponsor: Niguarda Hospital. Phase: NA. Conditions: Heart Failure

full page →ctgov ↗
← prev
page 113 of 163
next →